Plasminogen Activator Inhibitor-1 (PAI-1) is an Essential Driver of Cardiovascular Aging in Mice

被引：0
|
作者：
Kalousdian, Anthony
Soberanes, Saul
Eren, Mesut
Jorgensen, Emily
Lux, Elizabeth
Wilsbacher, Lisa D.
Vaughan, Douglas E.
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Aging; Cardiovascular disease; Hypertension; Blood pressure; Cardiovascular Risk;
D O I：
10.1161/circ.148.suppl_1.14009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14009
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture
    Xu, Zhi
    Castellino, Francis J.
    Ploplis, Victoria A.
    BLOOD, 2010, 115 (10) : 2038 - 2047
  • [22] Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice
    Mutoh, Michihiro
    Niho, Naoko
    Komiya, Masami
    Takahashi, Mami
    Ohtsubo, Rina
    Nakatogawa, Kiyoshi
    Ueda, Kentaro
    Sugimura, Takashi
    Wakabayashi, Keiji
    CARCINOGENESIS, 2008, 29 (04) : 824 - 829
  • [23] Phenotypic derangements associated with overexpression of plasminogen activator inhibitor-1 (PAI-1) in transgenic mice.
    Eren, M
    Su, M
    Atkinson, J
    King, L
    Declerck, P
    Vaughan, DE
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 695 - 695
  • [24] Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients
    Kowal, Krzysztof
    Zukowski, Sebastian
    Moniuszko, Marcin
    Bodzenta-Lukaszyk, Anna
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2008, 46 (02) : 193 - 198
  • [25] Do plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator PAI-1 complexes (tPA-PAI-1) Predict complications in type 1 diabetes (TID)?
    Bosnyak, Z
    Forrest, KYZ
    Maser, RE
    Orchard, TJ
    DIABETES, 2001, 50 : A209 - A209
  • [26] The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individuals
    Verschuur, M
    Jellema, A
    Bladbjerg, EM
    Feskens, EJM
    Mensink, RP
    Moller, L
    Vos, HL
    de Maat, MPM
    ATHEROSCLEROSIS, 2005, 181 (02) : 275 - 284
  • [27] THE CHARACTERIZATION OF A NOVEL INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN-VITRO
    FAINT, RW
    CHARLTON, P
    BENT, F
    BRYANS, J
    MACKIE, I
    BEVAN, P
    BLOOD, 1994, 84 (10) : A73 - A73
  • [28] Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments
    Hélène Party
    Cléo Dujarrier
    Marie Hébert
    Sophie Lenoir
    Sara Martinez de Lizarrondo
    Raphaël Delépée
    Claudine Fauchon
    Marie-Christine Bouton
    Pauline Obiang
    Olivier Godefroy
    Etienne Save
    Laurent Lecardeur
    Joëlle Chabry
    Denis Vivien
    Véronique Agin
    Acta Neuropathologica Communications, 7
  • [29] Plasminogen activator inhibitor-1(PAI-1) in early diabetic retinopathy and retinal neovascularization
    Das, A
    Menicucci, G
    Giebel, S
    Colombo, E
    McGuire, P
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [30] ISOLATION AND CHARACTERIZATION OF REACTIVATED FORMS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)
    DECLERCK, PJ
    DEMOL, M
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 653 - 653
12345